Dr. Albert Bourla episode artwork

EPISODE · Mar 21, 2022 · 30 MIN

Dr. Albert Bourla

from WSJ Opinion: Free Expression · host Gerard Baker, Editor at Large, The Wall Street Journal

On this episode of Free Expression, Wall Street Journal Editor-at-Large Gerry Baker speaks with Pfizer CEO Dr. Albert Bourla about how his company was able to develop a Covid-19 vaccine in under a year, the risks of new variants, and why some people distrust scientific institutions. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Episode metadata supplied by the publisher feed · Published Mar 21, 2022

Embed this episode

On this episode of Free Expression, Wall Street Journal Editor-at-Large Gerry Baker speaks with Pfizer CEO Dr. Albert Bourla about how his company was able to develop a Covid-19 vaccine in under a year, the risks of new variants, and why some people distrust scientific institutions.

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Dr. Albert Bourla

0:00 30:16

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of WSJ Opinion: Free Expression?

This episode is 30 minutes long.

When was this WSJ Opinion: Free Expression episode published?

This episode was published on March 21, 2022.

Can I download this WSJ Opinion: Free Expression episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!